GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,800
Closed -$752K 1677
2024
Q3
$752K Buy
6,800
+400
+6% +$41.8K ﹤0.01% 2430
2024
Q2
$629K Buy
6,400
+1,200
+23% +$122K ﹤0.01% 2489
2024
Q1
$582K Sell
5,200
-72,200
-93% -$7.79M ﹤0.01% 2452
2023
Q4
$7.8M Sell
77,400
-2,600
-3% -$258K 0.01% 737
2023
Q3
$6.95M Buy
+80,000
New +$7.23M 0.01% 763

Other funds holding CAH

GTS Securities's CAH Position: Q1 2026 in Review

GTS Securities reduced its Cardinal Health (CAH) stake by 72% in Q1 2026, selling an estimated $549K and leaving 1,013 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #1322.

GTS Securities first reported a position in CAH in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.47M in Q3 2023. 1,426 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • GTS Securities held 1,013 shares of Cardinal Health worth $214K as of Q1 2026.
  • GTS Securities sold 2,549 Cardinal Health shares in Q1 2026, an estimated $549K.
  • Cardinal Health made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1322 holding.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and has held it in 9 quarters since.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,426 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.